64
1 泌尿道感染之實證醫療 (Evidence-based treatment of UTI) 臺北市西園醫院 腎臟內科 教育副院長 徐偉岸醫師

泌尿道感染之實證醫療B9%EA%C3%D2%BA%F4%AD%B6/%B9… · 2. 報告大綱 泌尿道感染的定義及分類 實證為基礎的臨床診療指引 (Evidence-based clinical practice

Embed Size (px)

Citation preview

  • 1

    (Evidence-based treatment of UTI)

  • 2

    (Evidence-based clinical practice guideline)

    2002)

  • 3

    (infection)

    -

    -

    -

    -

    -

    -

    -

    -

    -

    -

    -

  • 4

    (urinary tract infectionUTI)

    (inflammatory response)

    Anthony J Schaeffer : Infections of the Urinary Tract in Campbells Urology, 7th ed, 1998

  • 5

    Acute cystitis in women

    E-coli, staphylococcus saprophyticus, proteus mirabilis, klebsiella pneumoniae

    Sexual history, personal hygeine. use of diaphragm, pregnancy, symptoms > 7 days

    Acute pyelonephritis in women

    E-coli, Proteus mirabilis, staphylococcus saprophyticus, klebsiella pneumoniae

    Sexual history, pregnancy,DM, foley catheter, children, age > 65 y/o, neurogenic bladder, renal stone,

    UTI in man

    E-coli, Proteus, Klebsiela, Pseudomonas, enterococcus, staphylococcus

    Sexual history,BPH, DM, foley catheter, children, age > 65 y/o, neurogenic bladder, renal stone,

  • 6

    (bacteriuria)

    ()

    (pyuria)

    (white blood cell)

    (urinary tract infection)

    Anthony J Schaeffer : Infections of the Urinary Tract in Campbells Urology, 7th ed, 1998

  • 7

    Urine culture and bacteriuria

    Urine culture(cfu/ml)

    Asymptomatic bacteriuria >= 100,000

    Pyelonephritis >=10,000

    Cystitis >=1,000

  • 8

    ()

  • 9

    ()

    uncomplicated UTI

    cystitis

    urethritis

    complicated UTI

    acute pyelonephritis

    chronic pyelonephritis

    renal abscess or carbuncle

    Urinary tract infection with host structural or immune abnormality.

    Male with urinary tract infection

    reinfection (another episode)

    bacterial persistence (same bacteria, not eradicated)

  • 10

    trimethoprim-sulfamethoxazole (TMP-SMX, Baktar)

    cephalosporins

    fluoroquinolones

    aminoglycosides

    nitrofurantoin

    aminopenicillins

    aztreonam

    Anthony J Schaeffer : Infections of the Urinary Tract in Campbells Urology, 7th ed, 1998

  • 11

    Evidence-Based Clinical Practice Guideline

  • 12

    ?

    David L. Sackett et al. (Ontario, Canada, 2000)

    :

    Evidence-based medicine (EBM) is the integration of best research evidence with clinical expertise and patient values.-

    ,

    ,.

  • 13

    , (),

    .

  • 14

    Systematic review of randomized control studies

    Single randomized control study

    Systematic review of observational studies

    Single observational study

    Physiologic studies

    Unsystematic clinical observationslow

    high

    Hierarchy of evidence

    Guyatt et al. 2002

    ( less bias )

    ( more bias )

  • 15

    ? (systematic review)

    ,

    , ,, .

    Systematic reviews are scientific investigations in themselves, with pre-planned methods and an assembly of original studies as their subjects. They synthesize the results of multiple primary investigations by using strategies that limit bias and random error.

    Mulrow & Cook, in Systematic Reviews - synthesis of best evidence for health care decisions, 1998, American College of Physicians.

  • 16

    National Guideline Clearinghouse

    National Guideline Clearinghouse

    Guideline

    ?

    National Guideline Clearinghouse (www.guideline.gov)

    http://www.guideline.gov/

  • 17

    National Guideline Clearinghouse

    Evidence-based clinical practice guidelines for patients 6 years of age or less with first time acute urinary tract infection.

    ( Childrens Hospital Medical Center, Cincinnati ,1999)

    Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women

    (Infectious Disease Society of America, IDSA 1999)

    Use of antibiotics in adults(Singapore Ministry of Health, MOH, 2000)

    !

  • 18

    (presumed UTI)

    Presumed UTI = UTI symptoms + abnormal urinalysis (pyuria)

    abnormal urinalysis

    (nitrite)

    esterase

    (microscopic exam)

  • 19

    (definite UTI)

    +

    Definite UTI=presumed UTI

    + positive urine cultutre

    (single

    organism)

    suprapubic aspirate (SPA) >= 1,000 cfu/ml

    catheter specimen (Cath)>=10,000 cfu/ml

    clean voided specimen ( CVS)>=100,000 cfu/ml

  • 20

    (Uncomplicated UTI)

    ,

  • 21

    (Complicated UTI)

    (VU reflux in children)

    (neurogenic bladder, BPH, stone, stricture or tumor)

  • 22

    (uncomplicated acute bacterial cystitis)

    3

    (dysuria)

    (frequency)

    (urgency)

    >1,000 cfu/ml

  • 23

    (acute pyelonephritis)

    (fever), / (flank pain)

    3 (dysuria)(frequency)

    (urgency)

    ( )

  • 24

    Recommended treatment for uncomplicated and complicated UTI

  • A( Ia Ib)

    (literature of good quality) (randomised, controlled trial)

    B( IIa IIbIII)

    C( IV)

    GPP (Good practice point)

    (guideline development group)

  • Ia (randomised, controlled trials)(meta-analysis)

    Ib (randomised, controlled trial)

    IIa (well-designed controlled study without

    randomisation)IIb

    (well-designed quasi-experimental study)III (non-

    experimental descriptive studies)

    IV

  • 27

    (asymptomatic bacteriuria)

    (A, Ib)

    -

  • 28

    (acute cystitis in women)

    ,

    (A, Ia)

    :

    trimethoprim/sulfamethoxazol 160/800 mg BID for 3 days (A, Ib)

    fluoroquinolones (ciprofloxacin 250mgofloxacin 200mgnorfloxacin 400mg)TID

    for 3 days (A, Ib)

    first or second generation of cephalosporins for 7 days (B, II)

    nitrofurantointrimethoprim for 7 days (B, II)

  • 29

    (recurrent cystitis in women)

    trimethoprim/sulfamethoxazol 40/200 mg

    nitrofurantoin 50 mg

    cephalexin 100 mg

    trimethoprim 100 mg

    (B, IIa)

  • 30

    () (acute pyelonephritis in women)

    cephalosporins

    - cephalexin 250 mg qidcefaroxil 500 mg bidcefuroxime 125 mg bid

    fluoroquinolones- ciprofloxacin 500 mg bidofloxacin 400 mg bidnorfloxacin 400 mg bid

    amoxicillin-clavulanic acid 375 mg tid

    trimethoprim/sulfamethoxazol 160/800 mg bid

    (14) (B, III)

  • 31

    () (acute pyelonephritis in women)

    ()!

    :

    - cephalosporins- fluoroquinolones- ampicillins plus aminoglycosides- cephalosporins plus aminoglycosides (B,III)

    cephalosporins plus aminoglycosides cephazolin 500 mg q8h or cefuroxime 750 mg q8h

    + gentamicin 1 mg/kg q8h

    24

    (14)

    (B, III)

  • 32

    (UTI in pregnancy)

    (asymptomatic bacteriuria)

    (A, Ia)

    (acute cystitis) cephalosporins

    nitrofurantointrimethoprim/sulfamethoxazole

    (7)

    (B, III)

    (acute pyelonephritis in pregnancy) cephalosporins

    (ceftriaxone 1 g)

    (14)

    (B, III)

  • 33

    (acute cystitis in adult men)

    /

    (STD)

    trimethoprim/sulfamethoxazol 160/800 mg bid

    fluoroquinolones

    ciprofloxacin 250mgofloxacin 200mg norfloxacin 400mg bid

    ~ (7~14)

    (C, IV)

  • 34

    (acute prostatitis)

    ,,

    (blood PSA,

    urine or prostate secretion culture)

    trimethoprim/sulfamethoxazol 160/800 mg bid

    fluoroquinolones

    ciprofloxacin 250mgofloxacin 200mg norfloxacin 400mgbid

    (28)

    (B, III)

  • 35

    (chronic bacterial prostatitis)

    ,

    , ,

    ,

    trimethoprim/sulfamethoxazol 160/800 mg bid

    fluoroquinolones

    ciprofloxacin 250mgofloxacin 200mg norfloxacin 400mgbid

    (84)

    (B, III)

  • 36

    (chronic abacterial prostatitis)

    doxycyclin 100 mg bid

    erythromycin 250mg qid

    (14)

    (C, IV)

  • 37

    (complicated UTI)

    fluoroquinolones

    trimethoprim/sulfamethoxazol

    (14) (A, Ib)

    cephalosporins

    (14) (C, IV)

  • 38

    (complicated UTI)

    cephalosporinsfluoroquinolones

    -lactam/

    -lactamase inhibitor

    (14

    )

    (C, IV)

    ampicillinaminoglycoside

    (14 )

    (C, IV)

  • 39

    (complicated UTI)

    (catheter-related UTI, bacteriuria 10~15%, UTI 3~5% per day of catheterization)

    ()

    (14 ~ 28)

    (UTI in renal failure) aminoglycoside()

    (14 ~ 42)

  • 40

    2002

  • 41

    19976-

    40

    34.6

    12.0

    10.5

    7.5

    5.4

    ---

    5.1

    3.9

    3.1

    1.8

    1.8

    (,1998)

  • 42

  • 43

    (2002)

    (1993)

    ( Mainous1998)

  • 44

  • 45

    ()

    2002

    12

  • 46

    ()

    National Guideline Clearinghouse (www.guideline.gov)

    1999

    2000

    http://www.guideline.gov/

  • 47

    WHO

  • 48

    /

    (over use)

    (under use)

  • 1.2.3.1.

    -*

    1.

    2.

    *(clinical practice guidelines)

  • 50

  • A. 200,000B. 2,572,065C. a. 11,008 (a/A = 5.5%)b. 26,129 (b/B = 1.02%)

    2.37/ (b/a)c. 134,051 5.13/(c/b)

    d. () 2.71e. 13,255 (e/c = 13.41)

  • Fluoroquinolone 2,817 31.92Nitrofurantoin 1,537 17.42Cephalosporin 4,138 46.89

    Trimethoprim - Sulfamethoxazole 333 3.77

    8,825 100.00

  • under use appropriate over use Total

    Fluoroquinolone 367(13.03) 1,828(64.89) 622(22.08) 2,817(100)

    Nitrofurantoin 1,343(87.38) 128(8.33) 66(4.29) 1,537(100)

    Cephalosporin 739(17.86) 3,209(77.55) 190(4.59) 4,138(100)

    Trimethoprim - Sulfamethoxazole 13(3.90) 135(40.54) 185(55.56) 333(100)

    4,264(27.90) 5,300(60.06) 1,063(12.05) 8,825(100)

  • Fluoroquinolone 39 16.88Cephalosporin 138 59.74

    Amoxicillin - Clavulanic acid 38 16.45

    Trimethoprim - Sulfamethoxazole

    16 6.93

    231 100.00

  • under use appropriate over use Total

    Fluoroquinolone 21(53.85) 16(41.02) 2(5.13) 39(100)

    Amoxicillin - Clavulanic acid 7(18.42) 19(50.00) 12(31.58) 38(100)

    Cephalosporin 81(58.7) 55(39.85) 2(1.45) 138(100)

    Trimethoprim - Sulfamethoxazole 4(25.00) 2(12.50) 10(62.50) 16(100)

    113(48.92) 92(39.83) 26(11.26) 231(100)

  • ()

    Odds ratio95

    -0.8606 0.1238

    (12~20)

    21-40 -0.0279 0.1110 0.972 0.782~1.209

    41-60 0.2641 0.1108 1.302* 1.048~1.618

    >60 0.4064 0.1154 1.501** 1.197~1.882

    ()

    -0.1231 0.0727 0.884 0.767~1.020

    -0.2781 0.0652 0.757 *** 0.666~0.860

    -0.0317 0.0725 1.311 0.959~1.792

    0.0472 0.0654 1.048 0.922~1.192

    -0.5769 0.1570 0.562** 0.413~0.760

    ()

    0.3721 0.1797 1.451* 1.020~2.064

    0.4524 0.1861 1.572* 1.092~2.264

    0.2788 0.1718 1.322 0.944~1.851

    *P

  • ()

    Odds Ratio95

    ()

    0.3017 0.1907 1.352 0.930~1.965

    0.1584 0.1799 1.172 0.823~1.667

    -0.1549 0.1798 0.857 0.602~1.219

    ()

    -0.3209 0.0969 0.725** 0.600~0.877

    0.2282 0.0918 1.256* 1.050~1.504

    0.2706 0.1595 1.311 0.959~1.792

    -0.5851 0.2594 0.557* 0.335~0.926

    0.4765 0.0698 1.610*** 1.405~1.846

    -0.1544 0.0933 0.857 0.714~1.029

    -0.2116 0.1727 0.809 0.577~1.135

    -0.4607 0.1836 0.631* 0.440~0.904

    -0.4107 0.3314 0.663 0.346~1.270#-2Log Likelihood=11575.1522=299.4373, DF=23(P

  • ()

    *P

  • ()

    *P

  • 60

    ()--FluoroquinoloneNitrofurantoinCephalosporin

    Trimethoprim Sulfamethoxazole

    60.06

    27.912.05

    cephalosporin46.89% 22.45%

    Trimethoprim Sulfamethoxazole3.77% 59.46%

    Nitrofurantoin17.42% 91.67%

    87.38%

  • 61

    ()--

  • 62

    ()--FluoroquinoloneCephalosporin Amoxicilli Clavulanic acidTrimethoprim Sulfamethoxazole

    48.92

    39.8311.26

    cephalosporin59.74%

    60.15% 58.7%

    Trimethoprim

    Sulfamethoxazole

    6.93% 87.5%

  • 63

    ()--

  • (Evidence-based treatment of UTI)(infection)(urinary tract infectionUTI)Urine culture and bacteriuria()() ? ?(systematic review)National Guideline Clearinghouse National Guideline Clearinghouse(presumed UTI)(definite UTI)(Uncomplicated UTI) (Complicated UTI) (uncomplicated acute bacterial cystitis)(acute pyelonephritis) 25 26 (asymptomatic bacteriuria)(acute cystitis in women) (recurrent cystitis in women)()(acute pyelonephritis in women)()(acute pyelonephritis in women) (UTI in pregnancy)(acute cystitis in adult men) (acute prostatitis) (chronic bacterial prostatitis) (chronic abacterial prostatitis) (complicated UTI)(complicated UTI)(complicated UTI) () ()/ ()()()()()--()--()--()-- 64